Keyphrases
Histone Deacetylase Inhibitor (HDACi)
100%
Bortezomib
100%
Cervical Cancer Prevention
100%
Cervical Cancer Cells
100%
Uterine Cervical Cancer
100%
High-risk Human Papillomavirus (HR-HPV)
75%
Cervical Cancer
75%
Human Papillomavirus Negative
75%
Vorinostat
50%
Histone Deacetylases
50%
Histone Deacetylase 1 (HDAC1)
50%
Trichostatin A
50%
Histone Deacetylase 2 (HDAC2)
50%
Cervical Cancer Cell Line
50%
E7 Oncoprotein
50%
Tumor Growth
25%
Xenograft
25%
Proteasome Activity
25%
In Situ
25%
Keratinocytes
25%
Cancer Xenograft
25%
Protease Inhibitors
25%
Cervical Carcinoma
25%
Immunohistochemical Analysis
25%
Molecular Response
25%
Tumor Protein p53 (TP53)
25%
Normal Epithelium
25%
Proteasomal Degradation
25%
Sensitivity Response
25%
Cancer Cell Death
25%
Cervical Dysplasia
25%
Cervical Epithelium
25%
E6 Oncoprotein
25%
HDlg
25%
Primary Keratinocytes
25%
Medicine and Dentistry
Cancer Therapy
100%
Cervical Cancer
100%
Proteasome
100%
Histone Deacetylase
100%
Wart Virus
75%
Bortezomib
50%
Cancer Cell
50%
Vorinostat
25%
Protein P53
25%
Xenograft
25%
Trichostatin A
25%
HDAC1
25%
Histone Deacetylase 2
25%
Cervical Cancer Cell Line
25%
Protein E7
25%
Keratinocyte
25%
Precursor
12%
Tumor Progression
12%
Proteasome Inhibitor
12%
Uterine Cervix Carcinoma
12%
Uterine Cervix Dysplasia
12%
Protein E6
12%
Cell Death
12%
Tumor Suppressor Protein
12%